Atlas Trials

Add-on Methotrexate for the Treatment of Schizophrenia

Clinical trial NCT03369795 · UNKNOWN

Trial details

NCT number
NCT03369795
Sponsor
Sheba Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2017-12-15
Primary completion
2020-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.